Lecture 8 - Flashcards

1
Q

How do Tumours avoid the anti-tumour immune response?

A

Can create an immunosuppressive micro environment

Tumour down regulates MHC class I molecules (escaping immune recognition)

Over express inhibitory ligands which inhibit T cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

How do Tumours avoid the anti-tumour immune response?

A

Can create an immunosuppressive micro environment

Tumour down regulates MHC class I molecules (escaping immune recognition)

Over express inhibitory ligands which inhibit T cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the point of checkpoint inhibitors?

A

The block the blockers, leading to T cell activationnn adn anti-tumour immune response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is an example of types of checkpoint inhibitors?

A

PD1 inhibitors
PDL1 inhibitors
CTLA-4 inhibitors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is an example of a PD1 inhibitor?

A

Nivolumab

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are tumour associated antigens?

A

Normal cell antigens that expresssed on normal tissue but are over expressed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is an example of a tumour associated antigens?

A

HER-2 seen in breast cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are tumour specific antigens?

A

Antigens that are not normally represent in normal healthy tissue

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How do we generate chimeric antigen receptor T cells?

A

Gene for Chimaeriic antigen receptor extracted
Inserted into lentivirus vector
Then gets inserted into a T cell by virus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What receptor do most T cell leukaemia express?

A

CD7

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the advantages of bispecific antibodies?

A

Off the shelf
Access
Favourable toxicity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are the disadvantages of bispecific antibodies?

A

Dependant on endogenous T cell function
Durability less clear
Long term administration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the benefit of CAR-T over bispecific antibodies?

A

CAR-T = single infusion

Bispecific =long term

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is cytokine release syndrome?

A

Where theres T cell expansion and activation due to over activation of the immune system

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are the symptoms of cytokine releases syndrome?

A

Fever
Chills
Nausea
Vomiting
Diarrhoea

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How do you treat cytokine release syndrome?

A

Steroids
Tociluzumab

17
Q

What is immune effector cell-associated neurotoxicity syndrome?

A

Complication of receiving immune CAR-T therapy

Where T cells begin destroying cancer cells and become dysregualated leading to lots of cytokines being releases

Inflammation leading o perturbed blood brain barrier

18
Q

How is immune effector cell-associated neurotoxicity syndrome treated?

A

Steroids

19
Q

What a re the tumour intrinsic reasons why T cell therapies fail?

A

Target antigen loss
Lineage switching
Loss of CD58

20
Q

What are the tumour extrinsic reasons why T cell therapies fail?

A

Limited CAR T-cell expansion
Reduced CAR T-cell persistence
T cell exhaustion/dysfunction